Running in reverse: Tau redirects mitochondrial electron flow toward neurodegeneration
In this issue of Neuron, Li et al. show that tau enters mitochondria and binds NDUFS3 to regulate reverse electron transport (RET) in a phosphorylation-dependent manner. RET promotes tau phosphorylation, forming a self-perpetuating loop that is exacerbated with stress and
[Editorial] Neurotrauma as a chronic disease: a call for integrated care
Almost a deacade ago, a Lancet Neurology Commission described why traumatic brain injury (TBI) “is not a single event, but can be a chronic and often progressive disease with long-term consequences”. TBI and spinal cord injury (SCI) can impose a
Physical activity in ALS: friend or foe?
The role of physical activity in ALS risk could depend on intensity, sex, genetics, timing and other factors In the paper by Gao et al, a higher level of overall physical activity — whether self-reported or device-measured — was associated
Neuroscience and AI: Emerging synergies
This issue marks the second installment in a three-part series that Neuron is devoting to NeuroAI this year. The series reflects a field that is moving unusually fast in both directions: artificial systems are increasingly used as working models of
Editors commentary
The actress Ellen Terry (1847–1928) attributed her success to the three I’s, ‘Industry, intelligence and imagination’. This is a tricolon—a useful rhetorical device that brings together ideas with a rhythm and places emphasis on the last element. What might be
Specialized vascular niches preserve adult neural circuits
In this issue of Neuron, Zhu et al. show that Netrin-4 from specialized arterial smooth muscle cells restrains a latent death pathway in a subset of adult sympathetic neurons, revealing a neurovascular mechanism that selectively maintains mature neural circuits through
Deconstructing the association of metformin with reduced incidence of seizures and improved seizure control
Metformin associated with less incident seizures and fewer seizures: understanding why by deconstructing correlation in electronic health records. The paper by Mbizvo and colleagues demonstrated a beneficial association between metformin in people without evidence for pre-diabetes on the rate of
[Editorial] Alzheimer’s disease testing needs evidence, ethics, and equity
Alzheimer’s disease clinical practice is entering a new era, with advances in diagnosis and therapy raising the possibility of earlier intervention and prevention of cognitive impairment. As access to diagnostic testing and therapy widens, implementation must be based on evidence,
Decoding the sleeping mind with AI
The sleeping brain processes memory-related semantic information, yet decoding such content remains challenging. Combining a large, openly shared sleep EEG dataset with neural contrastive learning, Chen et al., in this issue of Neuron, establish a promising framework for non-invasive decoding
Clinical utility of measuring circulating glial fibrillary acidic protein in severe stroke
Stroke is a global health concern, requiring early and accurate diagnosis for effective treatment. Differentiating between ischaemic stroke and haemorrhagic stroke is critical, as treatment strategies differ significantly. While neuroimaging is the gold standard for differential diagnosis of stroke code
Sculpting functional brain drainage
Mechanisms directing meningeal lymphatic development have remained largely unexplored. Tavares et al. identify macrophage-mediated sculpting as a developmental program that establishes cerebrospinal fluid drainage pathways, revealing how disrupted lymphatic maturation may contribute to neurodevelopmental disorders.
Steroids or immunoglobulin for CIDP first-line treatment: why not both?
In Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), 81% of patients respond well to at least one of the established first-line therapies: corticosteroids, immunoglobulin or plasma exchange (PLEX).1 2 However, studies comparing their efficacy and tolerability are limited. Nobile-Orazio et al showed
[Editorial] Epilepsy care must look beyond seizure control
More than 50 million people live with active epilepsy worldwide, making it one of the most common neurological conditions across the lifespan. More than 80% of this burden falls on poor regions, where specialist services and treatment are scarce, and
When less is more and when it isn’t: Microglial Spi1 and the limits of what we know
Microglia are key players in Alzheimer’s disease, but the transcriptional control of their phagocytic function remains unclear. Kim et al. show that mouse microglial Spi1 deletion worsens amyloid pathology by impairing Aβ clearance through Syk, Lyn, and Fcgr1, providing new
Beyond neurotoxicity: A new face of 6-hydroxydopamine in cancer immunity
In this issue of Neuron, Yu et al. show that 6-hydroxydopamine (6-OHDA) suppresses tumor growth beyond its established sympathetic neurotoxic activity by inducing a macrophage-TH1 immune axis, uncovering an unexpected immunomodulatory role with potential therapeutic implications for breast cancer.
[Editorial] Risk reduction as a crucial part of dementia prevention
Dementia is one of the most pressing health challenges of the 21st century. Around 57 million people were estimated to be living with dementia in 2021, a figure similar to the entire populations of Italy or Kenya; prevalence of dementia
Is it time for the removal of valproate restrictions in men? Further evidence from a new study
In a population-based cohort study by Razaz et al,1 risks of neurodevelopmental disorders in 2051 children of fathers taking valproate monotherapy during spermatogenesis were no different to those taking levetiracetam or lamotrigine. The authors demonstrate how this aligns with several
Editors commentary
Medical training historically was an apprenticeship. Trainees would work with a consultant, usually for an extended time, to build competence through collaboration. Oftentimes this was as part of a team (a ‘firm’ in the UK) with other trainees. This provided
Human astrocytes keep time with inflammation
In this issue of Neuron, Hill et al. show that sustained exposure to inflammatory mediators can drive human astrocytes through evolving reactive states, revealing time-dependent transcriptional, epigenetic, and immune-facing programs that remain remarkably plastic after the initiating stimulus is removed.
Dual versus mono antiplatelet therapy within 72 hours after onset for mild ischaemic stroke or transient ischaemic attack: meta-analysis of randomised controlled trials
Background Although previous evidence generally agreed on the short-term dual antiplatelet therapy (DAPT) for mild stroke or transient ischaemic attack (TIA), there is no consensus on the optimal threshold for stroke severity and initiation timing of DAPT. We conducted an
Limiting neurodegeneration in ALS: A phosphatase paves the way
Zheng et al. identify phosphatase PGAM5 as a novel promising target for the treatment of different amyotrophic lateral sclerosis subtypes. PGAM5 dephosphorylates and activates the stress-regulated mitochondrial peptidase OMA1, which elicits a maladaptive mitochondrial integrated stress response in motor neurons.
[Editorial] Making neurology care transitions work for young patients
For children and young people with neurological disorders, the transition from paediatric to adult neurology services is a vulnerable period, with risks of disruptions to continuity of care and optimum treatment, and—depending on diagnosis—avoidable deterioration. Updated UK guidance from the
Correction: How well do plasma Alzheimers disease biomarkers reflect the CSF amyloid status?
This article1 has been corrected after publication. The competing interests statement has been amended to note that author Robert Howard was an unpaid member of the scientific board of Synaptogenix.
A cytoplasmic turn in TDP-43 toxicity
TDP-43 dysfunction underlies multiple neurodegenerative diseases. In this issue of Neuron, Ye et al. uncover a link between TDP-43 loss of function and altered processing body (P-body) activity and identify the decapping scavenger DCPS as a genetic modifier of neurotoxicity.
Treatment of recurrent cerebral bifurcation aneurysms using flow diverter stent silk vista: A monocentric case series
The Neuroradiology Journal, Volume 39, Issue 3, Page 309-314, June 2026. ObjectiveTo evaluate the efficacy and safety of the Silk Vista flow diverter stent in treating recurrent cerebral bifurcation aneurysms, highlighting angiographic and clinical outcomes in a monocentric case series.MethodsA
Before synapses are lost: Do endogenous retroviruses drive microglial overpruning in autism spectrum disorders?
Endogenous retroviruses (ERVs) are epigenetically silenced genomic elements whose reactivation can influence host gene regulation. In this issue of Neuron, Chen et al. identify ERV-derived RNA-DNA hybrids that activate neuronal C4b, driving microglial synaptic overpruning and autism-like behaviors.
Editor’s commentary
Can you change the battery in your car key? Not so long ago the answer may well have been ‘no’ (or probably not): it would need a trip to the garage. Nowadays though, an internet search for the age and
Genetic risk in a warming world
In the JNNP paper by Bellampalli et al, the authors ask a timely and underexplored question: can inherited genetic variation determine who is biologically most vulnerable to rising ambient temperatures? By systematically identifying human genetic variants whose functional consequences depend
[Editorial] The US Parkinson’s disease community demands prevention
In March each year, advocates from the Parkinson’s disease community come together to campaign on Capitol Hill. This year, members of the Parkinson’s Policy Forum gathered again in Washington DC with the aim to urge Members of Congress “into policy
Not just muscle: Exercise-induced brain rewiring as a driver of endurance and metabolic adaptation
Kindel, Post et al. establish that VMH SF1 neurons in mice encode exercise history and mediate endurance gains and exercise-driven metabolic benefits. Activation of these neurons even without further exercise training sustains benefits, suggesting they may be a target of
Incidence and prevalence of vascular cognitive impairment in China: a systematic review and meta-analysis
Objective Given China’s rapid population ageing and substantial stroke burden, understanding the epidemiology of vascular cognitive impairment (VCI) is critical. This study aimed to systematically evaluate VCI prevalence and incidence in China from 1980 to 2023, and explore demographic and
[Editorial] Europe at a brain health crossroads
The importance of strengthening brain health and brain skills to transform patient outcomes and the economics of health systems and societies is gaining traction on policy agendas in Europe. Prevention of neurological diseases and delaying the progression of neurodegenerative conditions
A microglia depletion deep dive
PLX5622 is widely used to study microglia in health and disease. In this issue of Neuron, a new manuscript from Cao et al. unveils a non-microglial driver of phenotypes previously attributed to microglia and provides a roadmap for more effectively
Appropriate use recommendations in search of reimbursement: lecanemab and the UK dilemma
Mummery et al1 outline the recommendations for the appropriate use (AURs) of the amyloid-targeting monoclonal antibody lecanemab in clinical practice in the United Kingdom. These recommendations are published more than a year after the UK Medicines and Healthcare products Regulatory
Editors commentary
Evolution is a powerful force that applies to ideas as well as to species. This was recognised before Darwin wrote On the Origin of Species. He compared the evolution of species by natural selection with the previously recognised evolution of
Heterozygous variants in SLC12A6 should be considered in all cases of suspected inherited neuropathy
Charcot-Marie-Tooth (CMT) disease is the most common inherited neuropathy, frequently presenting with a heterogeneous clinical presentation. Over 100 CMT causative genes have been described. Homozygous variants in SLC12A6, which encodes a K-Cl cotransporter, had already been linked to Andermann syndrome
Rethinking two-photon voltage imaging
In this issue of Neuron, Grimm et al. describe the Jarvis voltage indicator, which demonstrates that scanless parallel two-photon excitation enables robust, high-speed voltage imaging in vivo, overturning prior assumptions about the incompatibility of rhodopsin-based indicators with two-photon microscopy.
Factors associated with post-dural puncture headache: A single-center retrospective review
The Neuroradiology Journal, Volume 39, Issue 2, Page 231-237, April 2026. ObjectivePost-dural puncture headache (PDPH) is potential complication after procedures with dural puncture. This study analyzes how patient and procedural factors are related to the development of PDPH.MethodsDemographic and procedural
Repeat expansion RNA elicits toxicity through hybrid G-quadruplexes with promoter DNA
In this Neuron issue, Liu et al. show that the C9orf72 expanded G4C2 repeat RNA forms hybrid G-quadruplexes with CG-rich promoter regions, which impedes RNA polymerase II. This process causes global transcriptional dysregulation in C9orf72 amyotrophic lateral sclerosis patient derived
[Editorial] Closing Europe’s stroke prevention and care gaps by 2030
In 2023, the burden of stroke accounted for approximately 157 million disability-adjusted life years (DALYs), ranking second among all non-communicable diseases globally. Although age-standardised rates of stroke mortality and DALYs have declined worldwide, the absolute burden continues to rise due
Lost rhythms: Breast cancer hijacks neuronal circuits that blunt GC rhythms to promote tumor progression
In this issue of Neuron, Gomez et al. report that breast cancer disrupts diurnal glucocorticoid oscillations by disinhibiting hypothalamic CRH neurons. Time-specific neuromodulation restores rhythms and attenuates tumor growth by enhancing CD8+ T cell functions. This unveils a mechanism whereby
Thrombolytic agents, more options, more challenges
Burned by experience: Epigenetic inflammatory memory in neurons drives synaptopathy after infection
Shammas et al. report that LCMV infection epigenetically primes hippocampal neurons for heightened responses to viral rechallenge, driving synaptopathy. These findings suggest epigenetic inflammatory memory in neurons, resembling previous observations in other CNS non-immune cells, and may guide therapeutic interventions.
[Editorial] Stopping Alzheimer’s disease before symptoms start
Dementia due to Alzheimer’s disease manifests years after the initial pathological changes in the brain. In fact, the deposition of amyloid plaques, and the subsequent tangles and neurodegeneration, can remain clinically silent for decades. This period presents a valuable opportunity
Quantification of muscle glycogen distribution in Pompe disease using 7 Tesla 13C NMR spectroscopy
Background Late-onset Pompe disease has a characteristic pattern of fat replacement and wasting of especially axial and hamstring muscles. This characteristic pattern of muscle degeneration is still to be explained but could relate to differences in how glycogen is deposited
Beyond blood pressure: Angiotensin II drives early brain injury
The mechanisms linking hypertension to cognitive decline remain unclear. Schaeffer et al. show that angiotensin II damages endothelium, oligodendrocyte precursors, and interneurons via AT1 signaling, independent of blood pressure. Targeting this pathway may protect the brain beyond pressure control alone.
From tumor metabolism to brain circuits: METTL14 as a SAM sensor driving pain-depression in pancreatic cancer
Our knowledge gaps regarding the mechanisms driving the varied signs and symptoms associated with malignancies are quickly being filled. In this edition, Yang et al. discover a critical connection linking pancreatic cancer and its associated comorbidities—pain and depression.
[Editorial] The value of patient experience in multiple sclerosis research
The number of therapies approved to treat multiple sclerosis has grown substantially over the past 20 years, yet many people living with the disease continue to have symptoms that are not adequately controlled. Traditionally, what matters to patients has not
Editors’ commentary
‘Mind the gap’ is a familiar announcement to anyone who has travelled on the trains in the UK or on the London Underground. The gap being referred to—’between the train and the platform edge’—varies between stations but sometimes is an
Epstein-Barr virus reactivation as a trigger in autoimmune GFAP astrocytopathy
Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is a rare Central Nervous System (CNS) inflammatory disorder, first defined in 2016 and identified by GFAP-IgG in cerebrospinal fluid (CSF). Its rarity makes large-scale studies nearly impossible, so each well-designed case series
How astrocytes regulate microglia in CNS injury: BST2-high astrocytes at the border
In this issue of Neuron, Zhang et al. identified a subset of BST2-high astrocytes that emerge at the ischemic injury border and promote microglial recruitment through the C3-C3aR pathway. These findings highlight BST2 as a key modulator of astrocyte-microglia communication
Young stroke in Bangladesh: addressing rare cases with diagnostic challenges and much-needed solutions
Stroke is a leading cause of mortality and morbidity in Bangladesh, and young adults are increasingly affected. Common risk factors include hypertension, diabetes, dyslipidaemia, obesity and smoking, whereas rare causes include haematologic disorders, premature atherosclerosis, vasculopathy and arteritis. Treatment barriers
Astrocyte in stroke: Location matters
In this issue of Neuron, Gleichman et al. reveal that astrocytes exhibit region-specific features after stroke. Cortical astrocytes, but not white matter astrocytes, leverage Lamc1 to promote vascular remodeling, highlighting the complexity of harnessing astrocytes for neurorepair.
IN MEMORIAM: Dr. Victoria E. Johnson
Journal of Neurotrauma, Volume 42, Issue 23-24, Page 2127-2128, December 2025.
Beyond the modified Rankin Scale: the unseen burden of stroke in young adults
The global burden of stroke in the young continues to grow, with rising incidence and prevalence placing increasing strain on healthcare systems. While stroke is typically associated with older adults, young stroke survivors—often amid career development, family life and other
Association Between Adherence to Guidelines and Patient Outcomes in Severe Pediatric Traumatic Brain Injury: A Scoping Review
Journal of Neurotrauma, Volume 42, Issue 19-20, Page 1663-1670, October 2025.
[Editorial] Turning policy into action for brain health
Neurological disorders are among the leading causes of disability worldwide, yet millions of people still lack access to effective care, particularly in low-income and middle-income countries (LMICs). A pivotal step to address these gaps was the adoption of the Intersectoral
Bi-directional communication between regulatory T cells and microglia promotes recovery from spinal cord injury
In this issue of Neuron, Qin et al. demonstrate that regulatory T cells (Tregs) are essential for tissue preservation and functional recovery after spinal cord injury, highlighting bilateral communication between Tregs and microglia as a key mechanism underlying Treg-mediated protection.
Metabolic stress, interneuron vulnerability, and cognitive decline
In this issue of Neuron, Landry et al. show how hippocampal cholecystokinin (CCK)-positive neurons respond to reduced glucose availability induced by a short-term high-fat diet and how changes in CCK neurons contribute to deficits in hippocampal-dependent cognitive function.
Association Between Adverse Childhood Experiences Score and Traumatic Brain Injury Occurrence: A Systematic Review and Meta-Analysis
Journal of Neurotrauma, Volume 42, Issue 21-22, Page 1907-1917, November 2025.
Editors commentary
The meaning of ‘prudence’ has evolved. Initially it meant foresight, but this has moved to mean wisdom, and then to wisdom mixed with increasing amounts of caution. It had quite a run in British politics when its meaning included less
Moving past NfL? Multibiomarker models for ALS prognosis and stratification
Over the past two decades, a multistep process has been proposed to explain amyotrophic lateral sclerosis (ALS) pathogenesis, implicating genetic factors, environmental exposures and time.1 These models require validation through robust clinical and biological measures of disease state and progression.
[Editorial] Celebrating decades of progress in Lewy bodies research
Three decades ago, in October 1995, an international group of researchers convened in Newcastle upon Tyne (England, UK) for the inaugural meeting of the Dementia with Lewy Bodies Consortium. This landmark event laid the foundation for the Consortium’s work in
Glutamate promotes glioma growth via a non-excitable, receptor tyrosine kinase-mediated mechanism
In this issue, Anastasaki et al. show that glutamate promotes proliferation of pilocytic astrocytoma cells. The authors demonstrate that glutamate receptors activate mitogenic PDGFRα signaling without altering the electrical properties of tumor cells, providing new understanding of how neurotransmitters enhance
Chinese stroke association guidelines on reperfusion therapy for acute ischaemic stroke 2024
Background Stroke remains a major global health challenge, with China experiencing a significant burden due to its high incidence and severe outcomes. Reperfusion therapies, such as intravenous thrombolysis and endovascular thrombectomy, have shown substantial benefits in improving early outcomes for
Friendship fights cancer
In this issue of Neuron, Wen et al. reveal that social interaction activates an ACC→BLA circuit in female breast cancer model mice, reducing anxiety, norepinephrine, and tumor growth. Circuit manipulations shift immunity toward cytotoxic T cells, uncovering a brain-immune pathway
[Editorial] Essential medicines for neurological disorders: updates, rejections, and the road ahead
Several updates relevant to neurologists and health-care professionals involved in the prevention and treatment of neurological diseases have been added to the WHO Model List of Essential Medicines (EML). The inclusion of drugs into “the world’s most influential list of
Neurological immune-related adverse events with immune checkpoint inhibitors: collaboration is key
Access to multidisciplinary teams improves outcomes in patients with neurological toxicity from cancer immunotherapies. Neurological immune-related adverse events (N-irAEs) from immune checkpoint inhibitors (ICI) are an infrequent (1%–5%) but well-recognised complication of treatment, with peripheral nervous system disorders predominating.1 As
Association Between Adherence to Guidelines and Patient Outcomes in Severe Pediatric Traumatic Brain Injury: A Scoping Review
Journal of Neurotrauma, Volume 42, Issue 19-20, Page 1663-1670, October 2025.
Unraveling neurovascular disease risk with MultiVINE-seq
In this issue of Neuron, Reid et al. introduce MultiVINE-seq, a single-nucleus multi-omic platform for profiling human cerebrovascular and perivascular cells for paired transcriptomic and epigenomic profiling. By integrating genome-wide association data, they map neurodegenerative and cerebrovascular disease risk variants
Unlocking the epigenome: Single-cell histone profiling in cortical development
Ditzer et al. used single-cell cytometry by time-of-flight-based method for epigenetic analysis to profile histone modifications in the primary human cortex and cortical organoids, revealing how chromatin states, particularly H3K27me3, govern neural progenitor fate. This study highlights the potential of
[Editorial] NINDS at the forefront of epilepsy research for 75 years
Despite advances in understanding their underlying mechanisms, many epilepsy disorders remain difficult to prevent, diagnose, or treat effectively. Research on early diagnosis and personalised care is essential for improving patient outcomes and quality of life. These aims are a core
Ecological Momentary Assessment in Acquired Brain Injury: A Scoping Review
Journal of Neurotrauma, Volume 42, Issue 17-18, Page 1465-1490, September 2025.
Editors commentary
The Pareto Principle, also called the 80/20 rule, applies to many aspects of life. There are examples in business where 80% of sales come from 20% of customers, in charity fundraising where 80% of donations are from 20% of donors,
Anticoagulation after intracerebral haemorrhage: clarity or confusion?
The meta-analysis by D’Anna et al in this journal addresses an enduring and complex clinical dilemma: should oral anticoagulation (OAC) be prescribed in intracerebral haemorrhage (ICH) survivors with atrial fibrillation (AF)?1 The balance between reducing ischaemic stroke risk and the
Next stop: Cancer neuroscience
Cancer neuroscience is an emerging and rapidly evolving interdisciplinary field that is reshaping our understanding of how the nervous system and cancers interact to affect underlying biology and clinical practice. We are pleased to present this special issue, which offers
Improved functional outcome for stroke patients with low ASPECTS score large core infarctions: 1-year follow-up of three randomised trials
Immunoregulator multitasking in neurons is not just a WHIM
Distinguishing direct from indirect mechanisms is often difficult in multisystem genetic conditions. In this issue of Neuron, Demenego et al. report that cerebellar malformation and dysfunction in WHIM syndrome immunodeficiency result from direct effects of hyperfunctional CXCR4 in neurons.
Frequency of Diffuse Axonal Injury and Its Outcomes in Severe Traumatic Brain Injury (sTBI): A Systematic Review and Meta-Analysis
Journal of Neurotrauma, Volume 42, Issue 15-16, Page 1243-1255, August 2025.
Ending nuclear weapons, before they end us
This May, the World Health Assembly (WHA) will vote on re-establishing a mandate for the WHO to address the health consequences of nuclear weapons and war.1 Health professionals and their associations should urge their governments to support such a mandate
[Editorial] Neurorehabilitation as a cornerstone of recovery
An estimated 3·4 billion people worldwide live with a neurological disease or the consequences of acquired brain injuries, including stroke, traumatic brain injury, and spinal cord injury. Neurological conditions are now the leading cause of disability worldwide. The ripple effects
The VI-P of the leptomeninges
The velum interpositum (VI) is a membranous extension of the leptomeninges under the hippocampus. In this issue of Neuron, Hohsfield et al. characterizes cellular properties of the VI in mice and its role as a gateway for myeloid cells infiltrating
A p16 pathway to prevention: Senescence as a driver of tau-mediated neurodegeneration
In this issue of Neuron, Graves et al. report that genetically reducing senescent cells by deleting p16 in a tauopathy mouse model significantly lessens tau pathology, neurovascular dysfunction, and behavioral deficits. Their study highlights the crucial role of p16-dependent senescence
[Editorial] Accelerating the path towards a cure for Parkinson’s disease
A plethora of treatments are available for the symptomatic management of Parkinson’s disease. However, patients still have substantial unmet needs mostly due to fluctuating treatment effectiveness and associated adverse effects and complications. Furthermore, no therapies can halt or slow disease
Biomarker-based Alzheimers diagnosis: learning to use p-tau217 wisely
The increasing complexity of personalised medicine to deliver targeted and highly specific therapeutics to patients for their disease depends on the diagnostic accuracy of our clinical medicine. The very large multicohort study of participants with and without cognitive impairment presented
Editors commentary
There is something about an Albert Einstein quotation that enhances any observation. Perhaps neurologists should be immune to such appeals to authority, but an editorial in this issue manages to sneak in four such Einsteinian epigrams. Authors reach for these
Marking a New Age in Characterization of Acute Traumatic Brain Injury: The National Institute of Neurological Disorders and Stroke Traumatic Brain Injury Classification and Nomenclature Initiative
Journal of Neurotrauma, Volume 42, Issue 13-14, Page 1021-1022, July 2025.
Fibromyalgia pain may have a gut solution
In this issue of Neuron, Cai et al. demonstrated that transferring fecal microbiota from fibromyalgia patients to mice confers pain hypersensitivity and depression-like behavior, which is reversed by fecal microbiota transplant from healthy donors. Fibromyalgia patients experience significant symptom relief
Association between ASPECTS region of infarction and clinical outcome in non-acute large vessel occlusion ischaemic stroke after endovascular recanalisation
Purpose This study retrospectively investigated whether infarction in specific Alberta Stroke Program Early CT Score (ASPECTS) regions is associated with clinical outcome in patients with symptomatic non-acute internal carotid or middle cerebral artery occlusion who underwent endovascular recanalisation (ER). Methods
Slowing the drive: A new regulatory break for nicotine reward-related behaviors
In this issue of Neuron, Jehl et al. developed a “suicide” antagonist to demonstrate that the interpeduncular nucleus acts as a regulatory controller of nicotine reward-related behavior through connections with the laterodorsal tegmental nucleus.
[Editorial] Honouring the amyotrophic lateral sclerosis research pledge
On April 22, 2025, the ALS Association and other advocacy groups (describing themselves as “the collective voice of the ALS community across the United States”) sent a letter to the ALS Congressional Caucus urging its members “to take immediate and
Seizures in pregnancy and child outcomes
Epilepsy is one of the most common neurological disorders that requires continued treatment during pregnancy.1 Seizure disorders occur in 0.3% to 0.8% of all gestations.2 3 Thus, antiseizure medications (ASMs) are frequently used during pregnancy because of the risks of
Dr. Jerry Silver—In Memoriam
Journal of Neurotrauma, Volume 42, Issue 11-12, Page 913-915, June 2025.
Combining old with new: A novel approach to studying human brain metabolism
In this issue of Neuron, Wang et al. provide a detailed assessment of the metabolites and lipids utilized by the whole human brain. They report that the brain consumes glucose, lactate, glutamate, and triglycerides while producing glutamine, pyruvate, and free
Rooted in regulation: MicroRNAs as gardeners of the Purkinje cell dendritic arbor
Zolboot et al.1 developed tools to manipulate and map microRNA function in cerebellar Purkinje cells with temporal precision, revealing key roles in dendritic development and circuit connectivity. Their approach provides insight into microRNA-mediated regulation of neurodevelopment in sparse neuronal populations.
[Editorial] A genetic framework for Alzheimer’s disease prevention
Genetics has been the steering force in establishing the biological framework for Alzheimer’s disease research. At the end of the past century, the identification of families in whom mutations disrupt amyloid processing—and almost inexorably cause Alzheimer’s disease—marked a paradigm shift
Editors commentary
One of the problems with newly recognised diseases is that they are usually not new. While there are new infections or reactions to new drugs causing truly novel diseases, most ‘new’ diseases have previously existed, unrecognised and undiagnosed, or (more
Preventing one disease is not enough for brain health
In their JNNP systematic review article, Senff et al analysed the role of overlapping risk factors on three diseases (stroke, dementia and late life depression).1 Brain disorders are the leading cause of disability in the world. Ageing and growth of
A gut-wrenching tale of neuronal distress
Neurons innervating the gut are on the frontlines of host-microbe interactions and thus exposed to a myriad of inflammatory and infectious insults. In this issue of Neuron, Forster, Jakob et al. reveal that diverse populations of gut-innervating neurons exhibit conserved responses
Blood-Based Protein Biomarkers in the Chronic Phase of Traumatic Brain Injury: A Systematic Review
Journal of Neurotrauma, Volume 42, Issue 9-10, Page 759-797, May 2025.
New rat model of spinal cord infarction with long-lasting functional disabilities generated by intraspinal injection of endothelin-1
Background The current method for generating an animal model of spinal cord (SC) infarction is highly invasive and permits only short-term observation, typically limited to 28 days. Objective We aimed to establish a rat model characterised by long-term survival and
Validation of the GCS−Pupil Scale in Traumatic Brain Injury: Incremental Prognostic Value of Pupillary Reactivity with GCS in the Prospective Observational Cohorts CENTER-TBI and TRACK-TBI
Journal of Neurotrauma, Volume 42, Issue 9-10, Page 798-813, May 2025.
Rosalind Franklin Society Proudly Announces the 2024 Award Recipient for Journal of Neurotrauma
Journal of Neurotrauma, Volume 42, Issue 7-8, Page 637-637, April 2025.
Astrocytic GPR37L1: A new guardian against the onset and chronicity of neuropathic pain
In this issue of Neuron, Xu et al. demonstrate that activating GPR37L1, a G-protein-coupled receptor that negatively regulates astrocytes, suppresses the onset and maintenance of neuropathic pain, an intractable chronic pain caused by nerve damage, thereby serving as a therapeutic target.
[Editorial] AI and neurology: an ethical path to innovation
Artificial intelligence (AI) is transforming neurological research, offering unprecedented opportunities for improving diagnosis, treatment, and management of neurological disorders. China and the USA lead this technology revolution due to substantial investments in AI-driven health-care initiatives. European countries have, up to
Imaging endolymphatic space of the inner ear in vestibular migraine
Background Vestibular migraine (VM), the most frequent episodic vertigo, is difficult to distinguish from Ménière’s disease (MD) because reliable biomarkers are missing. The classical proof of MD was an endolymphatic hydrops (EH). However, a few intravenous gadolinium-enhanced MRI studies of
Spotting multifaced actions of magnesium on NMDA receptors
NMDARs act as coincidence detectors for synaptic plasticity by activity-dependent relief of Mg2+ pore block. In this issue of Neuron, Huang et al. solved the structure of NMDARs to enlighten the fascinating actions of Mg2+ beyond its pore binding.
C5 complement inhibition and FcRn modulation in generalized myasthenia gravis. Fast-acting but short-lived therapies the use of which should prompt assertive escalation of conventional treatments
The paper by Huntemann et al1 exploits almost identical indications for the treatment of generalised myasthenia gravis (MG) with efgartigimod (a neonatal Fc receptor blocker (FcRn blocker)) and ravulizumab (a C5 complement inhibitor) to conduct an elegant real-world study comparing
Traumatic Brain Injury and Alzheimer’s Disease Biomarkers: A Systematic Review of Findings from Amyloid and Tau Positron Emission Tomography
Journal of Neurotrauma, Volume 42, Issue 5-6, Page 333-348, March 2025.
Differences in Network Functional Connectivity in Response to Sub-Symptomatic Exercise Between Elite Adult Athletes after Sport-Related Concussion and Healthy Matched Controls: A Pilot Study
Journal of Neurotrauma, Volume 42, Issue 5-6, Page 367-378, March 2025.
Calm in the chaos: Targeting mTOR to reduce glioma-driven neuronal hyperexcitability
Primary brain tumors induce neuronal hyperexcitability, leading to epileptic seizures. In this issue of Neuron, Goldberg et al. demonstrate genetic, structural, and functional alterations to excitatory tumor-associated neurons and how mTOR inhibition rapidly reverses these changes in a mouse model.
Navigating the presymptomatic frontier in genetic ALS and FTD
In the ever-evolving landscape of neurodegenerative diseases, recent genetic insights have opened new avenues of hope for prevention and early intervention in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).1 2 As our understanding of these devastating conditions grows, the
[Editorial] Advancing policies for rare diseases in Europe
Fostering dialogue between neurologists, researchers, patient representatives, and policymakers is an important step towards an equitable healthcare landscape that will enhance the quality of life of individuals with rare neurological diseases. Ahead of Rare Disease Day 2025, the European Federation
Editors commentary
Since the coming of the telegraph, we have had ever-increasing amounts of news, but such ‘news of the day’ comes with an ever-decreasing need for any personal action in response to it.1 The weather forecast might change our plans for
Fighting off a gut feeling: A gut-brain-lung neuroimmune circuit
In this issue of Neuron, Chen et al. identify a postprandial neuroimmune axis by which feeding-induced stimulation of the gastrointestinal tract triggers type 2 immunity in the lung. This study hints that there are likely distinct sensory and motor circuits coordinated
Patient-reported outcome measure and its application in patients with stroke: item response theory
Understanding the Measurement of Pressure Within the Spinal Cord to Optimize Spinal Cord Perfusion Pressure Using a Porcine Model of Spinal Cord Injury
Journal of Neurotrauma, Volume 42, Issue 3-4, Page 165-181, February 2025.
Stressed microglia turn to the dark side in Alzheimer’s disease
A microglia subpopulation termed “dark microglia” has been associated with aging and neurodegeneration, although its role has remained elusive. New research from Flury et al. in this issue of Neuron shows that dark microglia drive neurodegeneration via secretion of toxic lipids.
[Editorial] A pivotal recognition of the burden of encephalitis
Encephalitis International has marked February 22 as World Encephalitis Day since 2014. The non-profit organisation (previously named Encephalitis Society) works hard to advance research on and raise awareness of the needs of patients and carers. After a decade of multiple
Opposing and segregated cortical circuits control winning and losing behaviors
In this issue of Neuron, Xin et al. reveal how the dorsomedial prefrontal cortex (dmPFC) orchestrates social dominance through subcortical pathways to the amygdala and brainstem. Using optogenetics and functional mapping, they identify opposing win- and lose-related circuits, uncovering a laminar
Like, share, and spike: Glioblastoma progenitors influence neuronal excitability at the glioma-neural interface
Writing in Neuron, Zhang et al. identify a subpopulation of glioblastoma cells from patient tumor samples with progenitor-like features that expresses the potassium ion channel KCND2. In mouse and organoid models, these cells enhance neural activity at the glioma-neural interface.
[Editorial] Traumatic brain injury in older adults: a neglected challenge
Worldwide, at least 38 million people had a traumatic brain injury in 2021. The greatest burden of injury is faced by older people: disability-adjusted life years (DALYs; a measure of disease burden) are high in older adults (176·5 DALYs per
Behavioral and Cognitive Consequences of Spreading Depolarizations: A Translational Scoping Review
Journal of Neurotrauma, Volume 42, Issue 1-2, Page 1-18, January 2025.
Editors commentary
<p>Sometimes you have to step back to see what has changed. In this issue we publish the latest guidance from the Association of British Neurologists on using disease-modifying treatment in multiple sclerosis, written by their advisory group on MS and
Biomarkers of long-term consequences of traumatic brain injuries sustained during military service
Traumatic brain injuries (TBIs) have been a common consequence of combat since prehistoric times, and injuries to the cranium are commonly found in skeletal remains of prehistoric humans, most of which are likely a consequence of warfare.1 While physicians have
The neuroscience of aging: Shining a candle in the dark
Aging is inevitable. While healthy aging is the goal, old age is frequently accompanied by disheartening effects on physical function, cognition, and overall well-being. Additionally, while the causes of disease are multifactorial and dizzyingly complex, they tend to converge on
Design of trials in lacunar stroke and cerebral small vessel disease: review and experience with the LACunar Intervention Trial 2 (LACI-2)
Cerebral small vessel disease (cSVD) causes lacunar stroke (25% of ischaemic strokes), haemorrhage, dementia, physical frailty, or is ‘covert’, but has no specific treatment. Uncertainties about the design of clinical trials in cSVD, which patients to include or outcomes to
Give me a sign(ature): Converging on the CSC of glioblastoma
The identification of stem cells in glioblastomas has been controversial. In this issue of Neuron, Xie et al. establish gene signatures for cellular states and a quiescent cancer stem cell (qCSC) and demonstrate that the qCSC population expands in recurrence.
[Editorial] Bridging the diagnostic gap in Alzheimer’s disease
The introduction into clinical practice of disease-modifying treatment for Alzheimer’s disease has begun to bring hope to millions of people living with the disease. However, a concerted and coordinated effort between governments, non-profit organisations, researchers, and the private sector is
Paternal exposure to antiseizure medications and offspring outcomes
Is there evidence to support restrictions in the use of valproate in male patients? This issue is addressed in a JNNP systematic review presented in the paper by Honybun et al.1 The review provides a comprehensive assessment of different teratogenic
Normative Neuroimaging Library: Designing a Comprehensive and Demographically Diverse Dataset of Healthy Controls to Support Traumatic Brain Injury Diagnostic and Therapeutic Development
Journal of Neurotrauma, Volume 41, Issue 23-24, Page 2497-2512, December 2024.
Genetic risk factors for late-onset Alzheimer’s disease drive senescence in female tauopathy mice
Carling et al. report that late-onset Alzheimer’s disease (LOAD) risk alleles drive cellular senescence, a hallmark of aging, in a tau- and sex-dependent manner. Mechanistic insights into interactions among genetic risk, biological aging, and sex differences in LOAD are presented.
Slc-ing cone synapses: Na⁺/bicarbonate co-transport regulates synaptic gain
Horizontal cells provide feedback inhibition to cone axon terminals via an unidentified synaptic mechanism. In this issue of Neuron, Morikawa and colleagues demonstrate that the electrogenic bicarbonate transporter (Slc4a5), which regulates pH, plays a crucial role at this feedback synapse.
[Editorial] United action is needed to prioritise brain health
More than 3·4 billion people have conditions that affect the nervous system, and together such conditions are the leading cause of disease burden worldwide. This burden is increasing, but brain health still does not seem to be a high enough
Is There an Optimal Time Window of Placement of Intracranial Pressure (ICP) Monitor for Elderly Patients With Severe Traumatic Brain Injury? An 11-Year Institutional Cohort Study With Restricted Cubic Spline Analysis
Journal of Neurotrauma, Volume 41, Issue 21-22, Page 2363-2376, November 2024.
Cyclophosphamide for myasthenia gravis: a comeback?
Myasthenia gravis (MG) treatment’s landscape has dramatically changed with the approval of novel therapeutics that can provide rapid improvement, including in patients typically considered refractory. These treatments are a welcome addition in MG, since a proportion of patients traditionally considered
Editors’ commentary
There is tension in neurology between sub-specialism and generalism, something discussed in this issue through a geographically based metaphor. Bas Bloem and colleagues make the specialist’s case that complexity within neurology’s subspecialties leads to islands of expertise, and the need
Natural behavior relaxes zoning divisions in the brain
Technological advances allow neurophysiologists to explore the brain during natural behaviors, revealing new functional principles and challenging old ones. In this issue of Neuron, Li and colleagues show that the traditional parcellation of the marmoset frontal cortex does not apply
CSA declaration of next-generation reperfusion therapy for ischaemic stroke
Editorial Commentary on NEU-2023-0576, “Acute Development of Traumatic Intracranial Aneurysms Following Civilian Gunshot Wounds to the Head”
Journal of Neurotrauma, Volume 41, Issue 19-20, Page 2199-2200, October 2024.
Editorial Commentary on NEU-2023-0576, “Acute Development of Traumatic Intracranial Aneurysms Following Civilian Gunshot Wounds to the Head”
Journal of Neurotrauma, Volume 41, Issue 19-20, Page 2199-2200, October 2024.
When rewards backfire: Collapsing under pressure in motor cortex
People often underperform their abilities in high-value situations, a mysterious phenomenon known as “choking under pressure.” In this issue of Neuron, Smoulder et al. report that target-selective signals in the motor cortex of non-human primates collapse in the face of high-value
[Editorial] Dementia-related stigma is still pervasive
World Alzheimer’s Month takes place every September, a period during which some non-profit organisations—led by Alzheimer’s Disease International (ADI)—aim to raise awareness globally about dementia. An objective of the 2024 international campaign by ADI is to address the stigma and
Highlighting the past and future of inherited peripheral neuropathies
Inherited peripheral neuropathies (IPN) are among the most common inherited conditions in Neurology and are still largely not treatable. It is thus of great medical and public interest to understand IPN aetiologies more fully and enable the rational development of
Insights into mechanisms and therapeutic avenues for primary familial brain calcification
The diverse etiologies of the genetic neurodegenerative disorder known as primary familial brain calcification have dimmed hopes for curative therapies. However, two new papers in Neuron provide a reason for optimism by identifying mechanisms involved in brain phosphate transport and
Protective lifelines: Tunneling nanotubes connect neurons and microglia
Tunneling nanotubes (TNTs) facilitate the exchange of intracellular cargo between cells. In this issue of Neuron, Scheiblich et al. reveal that TNTs selectively mediate the bidirectional transfer of cytoplasmic protein aggregates from neurons to microglia and mitochondria from microglia to neurons,
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Journal of Neurotrauma
Journal of Neurotrauma, Volume 41, Issue 17-18, Page 2055-2055, September 2024.
[Editorial] Improving access to medicines for neurological disorders
Disorders affecting the nervous system are now the leading cause of disease burden globally, presenting a substantial public health challenge. WHO’s first policy tool to tackle this challenge is its Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders
Weighing the impact of post hoc studies
In their JNNP study, Dr Sun et al report post hoc analyses of data from the ‘Minimally Invasive Surgery plus Alteplase for Intracerebral haemorrhage Evacuation trial (MISTIE III)’.1 2 The parent study was a randomised open-label trial comparing image-guided minimally
Editors commentary
Even experienced neurologists must sometimes step back from a difficult clinical problem, take out the surgical sieve from their metaphorical cupboard, and check they are not missing something. The sieve provides a reminder that alongside the more common explanations we
Plaudits for logits in sensory neuroscience
A workhorse tool of economic decision-making has long sought to get inside people’s heads through careful examination of their choices. In this issue of Neuron, Carandini flips the script, showing how it can model how the brain makes sensory choices.
Time to treat the climate and nature crisis as one indivisible global health emergency
Characteristics and Neural Mechanisms of Sleep–Wake Disturbances After Traumatic Brain Injury
Journal of Neurotrauma, Volume 41, Issue 15-16, Page 1813-1826, August 2024.
Microglia’s heroic battle against neurodegeneration
In this issue of Neuron, Chadarevian et al. and Munro et al. demonstrate how the absence of homeostatic microglia leads to severe neuropathologies, including axonal spheroids, calcifications, myelination abnormalities, and gliosis, associated with leukoencephalopathy and age-related neurodegeneration. Transplantation of healthy microglia can
Predicting how many people might receive treatment with new therapies for Alzheimers disease
One hundred and seventeen years after Alzheimer described the condition that bears his name, the first treatments have been identified which appear to modify its course.1 2 These treatments are monoclonal antibodies which clear one of the presumed pathogenic proteins
[Editorial] The evolving paradigm of Alzheimer’s disease diagnosis
After a long process, not free of controversy, a task force convened by the Alzheimer’s Association has outlined criteria to facilitate clinical research, and to assist clinicians in the evaluation of people with cognitive impairment. The highly anticipated Revised criteria
Effectiveness of Non-Pharmacological Therapy on Physical Symptoms in Patients With Persistent Concussion Symptoms: A Systematic Review
Journal of Neurotrauma, Volume 41, Issue 13-14, Page 1473-1493, July 2024.
Cerebral Lactate Uptake After Half-Molar Sodium Lactate Therapy in Traumatic Brain Injury: A Brief Report
Journal of Neurotrauma, Volume 41, Issue 13-14, Page e1807-e1811, July 2024.
Injuries in Fatalities of Dismounted Blast: Identification of Four Mechanisms of Head and Spine Injury
Journal of Neurotrauma, Volume 41, Issue 13-14, Page e1680-e1686, July 2024.
Alpha synuclein PET imaging, a step closer to in vivo neuropathology in Parkinson’s disease and related disorders
In this issue of Neuron, Endo et al. develop a PET tracer capable of detecting alpha-synuclein (ɑ-syn). With validation in animal models and humans, this tracer brings us closer to being able to monitor the synuclein aggregation process and associated pathological
Correction to:Modulation of ABCA1 by an LXR Agonist Reduces Beta-Amyloid Levels and Improves Outcome After Traumatic Brain Injury by Loane DJ, Washington PM, Vardanian L, et al., DOI: 10.1089/neu.2010.1595
Journal of Neurotrauma, Volume 41, Issue 13-14, Page 1810-1811, July 2024.
Thalamic cells and pathway for social memory processing and storage
In this issue of Neuron, Wang et al. demonstrate that parvalbumin interneurons in the sensory thalamic reticular nucleus are necessary and sufficient for regulating social memory in mice, identify a novel cortico-reticular thalamic-parafascicular pathway for social cognition, and highlight an essential
[Editorial] A real chance to reduce death and disability from stroke
Stroke remains a major cause of death and disability worldwide, despite developments such as thrombolysis and endovascular thrombectomy. As highlighted at the 77th World Health Assembly (WHA) on May 27, 2024, in a side-event organised by the World Stroke Organization
Editors commentary
At neurology academic meetings at the end of the last century, neurologists would joke that in the future patients would have MR scans of their brain and spine and an analysis of their whole genome, and so neurology would be
Antiseizure medication and early pregnancy loss: should we be worried?
Each year, a large number of pregnancies are exposed to antiseizure medication (ASM) worldwide, when women treated with ASMs for conditions such as epilepsy, bipolar disorder, anxiety, depression, migraine or neuropathic pain become pregnant, and the use is rising.1 The
Pericytes: Unsung heroes in myelin repair after neonatal brain hypoxia
Preterm infants can face lasting neurodevelopmental challenges due to hypoxia-induced injury of the cerebral white matter. In this issue of Neuron, Ren et al. identify microvascular pericytes as unexpected targets for growth hormone signaling, which enhances angiogenesis and remyelination after hypoxic
Stroke depression: a concept with clinical applicability
Stroke is a common neurological condition and among the leading causes of death and disability worldwide. Depression is both a risk factor for and complication of stroke, and the two conditions may have a complex reciprocal relationship over time. However,
Emergency Department Risk Factors for Post-Concussion Syndrome After Mild Traumatic Brain Injury: A Systematic Review
Journal of Neurotrauma, Volume 41, Issue 11-12, Page 1253-1270, June 2024.
Eyes on glutamate in angiogenesis and barrier formation
In this issue of Neuron, Biswas et al. demonstrate the roles of glutamatergic neuronal activity in the regulation of angiogenesis and retinal vascular endothelial barrier maturation using three different knockout mouse models. Their findings shed light on how aberrant glutamatergic activity
Evaluating Recovery After Two and Three Repeated Concussions Using Growth Curves
Journal of Neurotrauma, Volume 41, Issue 11-12, Page 1409-1416, June 2024.
Searches for biomarkers using highly sensitive techniques might reveal more about pathogenesis of a disease than provide clinically useful molecular tests
The era of modern medicine is often linked to the first clinical application of penicillin in 1943.1 How far we have come in 80 years where we can now identify and measure concentrations of biomarkers in body fluids equivalent to
[Editorial] Multidisciplinary care for amyotrophic lateral sclerosis
The management of amyotrophic lateral sclerosis (ALS) is in the spotlight as trial results are published and regulatory decisions on therapies are made. In Europe, the antisense oligonucleotide tofersen, which targets mutations in the SOD1 gene, is expected to be
Seq-ing mechanisms behind types of Alzheimer’s disease
Sporadic Alzheimer’s disease (AD) and autosomal dominant Alzheimer’s disease (ADAD) share pathological features, but differing mechanisms, leading to disease. In this issue of Neuron, Almeida, Eger, et al. uncovered molecular processes that may distinguish sporadic AD from ADAD and how the
Genetic or Pharmacological Ablation of Acid-Sensing Ion Channel 1a (ASIC1a) Is Not Neuroprotective in a Mouse Model of Spinal Cord Injury
Journal of Neurotrauma, Volume 41, Issue 9-10, Page 1007-1019, May 2024.
Impact of Activity-Based Training on Bowel Function in a Rat Model of Spinal Cord Injury
Journal of Neurotrauma, Volume 41, Issue 9-10, Page 1181-1195, May 2024.
Correction: Neurological gait assessment
Mermelstein S, Barbosa P, Kaski D. Neurological gait assessment. Pract Neurol 2024;24:11-21. doi: 10.1136/pn-2023-003917. The authors are grateful to a reader who highlighted a typo in the article. Instead of ‘…peroneal neuropathy can be differentiated from L5 radiculopathy by preserved
Consciousness
Interest in the neurobiological substrates of consciousness has risen dramatically over the last few decades. This is reflected both in the steady increase in the number of papers published and in the recent surge of adversarial collaborations, in which researchers
[Editorial] Forging ahead in haemorrhagic stroke research
Haemorrhagic stroke has a poor prognosis and is challenging to treat. However, strides in research over the past few years mean that promising treatment and secondary prevention strategies are emerging. Researchers are tackling the major issues in haemorrhagic stroke, including
The tip of the iceberg in ATTRv: when to start carrier monitoring and when to initiate treatment?
The JNNP paper by Beauvais et al. reports a retrospective study on 130 transthyretin (TTR) mutation carriers with normal nerve conduction studies (indicating no large-fibre neuropathy) irrespective of the presence of symptoms of TTR-related amyloidosis (ATTRv).1 Carriers were submitted to
Keep calm and make neurons: The effects of glucocorticoids on human cortical neurogenesis
Maternal well-being is important for the development of the fetus, with a key influence on its nervous system. In this issue of Neuron, Krontira et al. implicate glucocorticoids, the stress hormones, in the regulation of neural stem cell identity and proliferation,
Implications of MMP-12 in the pathophysiology of ischaemic stroke
This article focuses on the emerging role of matrix metalloproteinase-12 (MMP-12) in ischaemic stroke (IS). MMP-12 expression in the brain increases dramatically in animal models of IS, and its suppression reduces brain damage and promotes neurological, sensorimotor and cognitive functional
14-3-3θ, a novel player in TDP-43 pathophysiology: Implications for ALS/FTD
In this issue of Neuron, Ke et al. report a novel non-canonical interaction between 14-3-3θ and TDP-43 that impacts loss-of-function and gain-of-toxic pathology in TDP-43 proteinopathies. The authors further provide proof of principle for a 14-3-3θ-targeted gene therapy to reduce TDP-43-induced
[Editorial] Important lessons on healthcare from rare diseases
Promoting the wellbeing of its citizens, fighting discrimination, and supporting scientific progress are among core values of the European Union (EU), where the rare diseases community must be commended for translating these values into actions. After two decades of intense
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)
Natalizumab treatment in relapsing-remitting multiple sclerosis: can we safely personalise treatment intervals? In JNNP, Toorop and coworkers present the results of the NEXT-MS trial, a clinical trial on individualised extended interval dosing (EID) of natalizumab (NTZ) in people with relapsing-remitting
Traumatic Brain Injury Effects on the Next Generation
Journal of Neurotrauma, Volume 41, Issue 7-8, Page 751-751, April 2024.
APOE loss of function: A genetic shield against Alzheimer’s disease
In this issue of Neuron, Chemparathy et al. provide human genetics data suggesting that APOE loss-of-function mutations may confer resistance to Alzheimer’s disease (AD) without compromising longevity. These data strongly support the APOE toxic gain-of-function hypothesis for AD.
A sympathetic brake on gut GLP-1 release
The brain-gut neurocircuitry is proving to be finely involved in a wide range of physiological functions. In this issue of Neuron, Ren et al. show that adrenergic signaling suppresses postprandial glucagon-like peptide 1 (GLP-1) secretion. This, in turn, raises circulating glucose
Correction: Amantadine toxicity causing visual hallucinations
Barbara JM, Pace A. Amantadine toxicity causing visual hallucinations. Pract Neurol 2023;23:418-419. doi: 10.1136/pn-2023-003723. Amantadine was incorrectly listed as an N-metyhl-d-aspartate (NMDA) receptor agonist twice in the text. Once in the abstract and once in the second paragraph of the
[Editorial] Increasing awareness of the need for brain health
Neurological disorders are affecting the lives of increasing numbers of people. New data from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) indicate that, in 2021, 3·4 billion people—more than 40% of the world’s population—had a condition
Correction: ICARUS study: prevalence and clinical features of impulse control disorders in Parkinsons disease
Antonini A, Barone P, Bonuccelli U, et al. ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson’s disease J Neurol Neurosurg Psychiatry 2017;88:317–324. doi: 10.1136/jnnp-2016-315277 Since this paper was first published Mirko Avesani and Francesco Palandin have
Rebuilding the behavioral inhibition circuit to prevent opioid relapse
Failure in behavioral suppression is a key feature in substance use disorders, potentially leading to compulsive drug seeking and relapse. In this issue of Neuron, Paniccia et al. elucidated a heroin-damaged paraventricular thalamo (PVT)-accumbal circuit and how recovery of PVT function
Longitudinal Brain Perfusion and Symptom Presentation Following Pediatric Concussion: A Pediatric Concussion Assessment of Rest and Exertion+MRI (PedCARE+MRI) Substudy
Journal of Neurotrauma, Volume 41, Issue 5-6, Page 552-570, March 2024.
Ten-year follow-up investigation of stroke risk in systemic lupus erythematosus
Background and purpose To analyse the long-term risk of ischaemic stroke and the clinical effects of antithrombotics on the risk of haemorrhagic stroke in patients with systemic lupus erythematosus (SLE). Methods A retrospective cohort study was conducted using a population-based
Driving valence-specific behavior through single-cell resolution control in the amygdala
In this issue of Neuron, Piantadosi et al. demonstrate that by precisely controlling the activity of individual negative-valence neurons and positive-valence neurons in the basolateral amygdala, one can alter animals’ appetitive or aversive responses, respectively, establishing a causal role of these
[Editorial] Dementia diagnosis in the anti-amyloid era
In Europe, the number of people at risk of cognitive impairment is expected to rise significantly in the coming years, because of the rapid ageing of its population. The advent of disease-modifying drugs for Alzheimer’s disease offers hope. The anti-amyloid
Genetics, cell biology and a novel mechanism for ALS
Disrupted homeostasis in sphingolipid synthesis causes severe ALS in young children Syeda and colleagues used an elegant combination of genetics, meticulous clinical evaluation and cell biology to demonstrate that disrupting serine palmitoyl transferase (SPT) can cause amyotrophic lateral sclerosis (ALS)
Does high-frequency stimulation of sensory axons break the causal link between pain relief and paresthesia?
Neurostimulation produces unnatural cutaneous sensations with potent analgesic effects in pain syndromes. In this issue of Neuron, Sagalajev et al. demonstrate that these sensations are an epiphenomenon and explain how high-frequency stimulation can provide analgesia without these unnecessary sensations.
New Findings in Long-Neglected Areas of Traumatic Brain Injury Research: Intimate Partner Violence, Effects of Neighborhood Disadvantage, and Racial Differences in Pain Catastrophizing
Journal of Neurotrauma, Volume 41, Issue 3-4, Page 303-304, February 2024.
Editors commentary
Teaching is a potent stimulus for learning, though it often provides a greater stimulus to the teacher than to the student. In everyday practice there are areas in which we are confident in our knowledge (known knowns), others where we
